CPS
  • Home

Sign in or register to track your progress, save, and view your completed history.

Breast Cancer, Cervical Cancer, Esophageal Cancer, Gastric Cancer, Head & Neck Cancer, Urothelial Carcinoma​

Scoring Near the CPS Cutoffs: Real-World Approaches

    clockimg 9m
  • Tutorial
  • Advanced
 saveimgSave unsaveimgUnsave

In this PD-L1 IHC 22C3 pharmDx Tutorial Video, you will learn to:​

  • Describe the approaches and rationale for determining PD-L1 expression level near the Combined Positive Score (CPS) ≥ 1 and CPS ≥ 10 cutoffs  ​
  • Identify when the Numerator Target, Hotspot, and Rolling Methods should be used​
  • Confidently determine PD-L1 expression level using CPS​

 

Agilent’s PD-L1 IHC 22C3 pharmDx tutorial videos are an engaging and convenient resource for advancing your knowledge of PD-L1 interpretation using Tumor Proportion Score (TPS) and CPS). Through these trainings we will help you to confidently:​

  • Understand the fundamentals of TPS and CPS including key inclusion and exclusion criteria for evaluation​
  • Navigate challenging morphology and staining characteristics​
  • Apply helpful strategies to confidently determine PD-L1 expression levels using TPS and CPS​

Related Training

This website addresses general principles for CDx scoring and is for education purposes only. Not all cancer indications mentioned are approved worldwide. Please refer to local Instructions for Use for further details.​​D0113778_1.00